Shandong Buchang Pharmaceuticals Statistics

Total Valuation

Shandong Buchang Pharmaceuticals has a market cap or net worth of CNY 16.22 billion. The enterprise value is 18.48 billion.

Market Cap	16.22B
Enterprise Value	18.48B

Important Dates

The next estimated earnings date is Saturday, April 26, 2025.

Earnings Date	Apr 26, 2025
Ex-Dividend Date	Aug 20, 2024

Share Statistics

Shandong Buchang Pharmaceuticals has 1.07 billion shares outstanding. The number of shares has decreased by -1.09% in one year.

Current Share Class	n/a
Shares Outstanding	1.07B
Shares Change (YoY)	-1.09%
Shares Change (QoQ)	-1.38%
Owned by Insiders (%)	58.38%
Owned by Institutions (%)	6.36%
Float	416.21M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.41
PB Ratio	1.45
P/TBV Ratio	1.83
P/FCF Ratio	27.74
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.53, with an EV/FCF ratio of 31.60.

EV / Earnings	-63.01
EV / Sales	1.57
EV / EBITDA	19.53
EV / EBIT	32.32
EV / FCF	31.60

Financial Position

The company has a current ratio of 1.24, with a Debt / Equity ratio of 0.36.

Current Ratio	1.24
Quick Ratio	0.46
Debt / Equity	0.36
Debt / EBITDA	4.15
Debt / FCF	6.72
Interest Coverage	4.77

Financial Efficiency

Return on equity (ROE) is -4.04% and return on invested capital (ROIC) is 2.37%.

Return on Equity (ROE)	-4.04%
Return on Assets (ROA)	1.75%
Return on Capital (ROIC)	2.37%
Revenue Per Employee	1.42M
Profits Per Employee	-35,291
Employee Count	8,311
Asset Turnover	0.58
Inventory Turnover	1.06

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -9.77% in the last 52 weeks. The beta is 0.52, so Shandong Buchang Pharmaceuticals's price volatility has been lower than the market average.

Beta (5Y)	0.52
52-Week Price Change	-9.77%
50-Day Moving Average	16.82
200-Day Moving Average	16.14
Relative Strength Index (RSI)	26.57
Average Volume (20 Days)	5,070,652

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Shandong Buchang Pharmaceuticals had revenue of CNY 11.78 billion and -293.31 million in losses. Loss per share was -0.27.

Revenue	11.78B
Gross Profit	6.93B
Operating Income	571.87M
Pretax Income	-184.40M
Net Income	-293.31M
EBITDA	930.24M
EBIT	571.87M
Loss Per Share	-0.27

Full Income Statement

Balance Sheet

The company has 1.31 billion in cash and 3.93 billion in debt, giving a net cash position of -2.62 billion or -2.46 per share.

Cash & Cash Equivalents	1.31B
Total Debt	3.93B
Net Cash	-2.62B
Net Cash Per Share	-2.46
Equity (Book Value)	10.80B
Book Value Per Share	10.47
Working Capital	1.47B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 917.66 million and capital expenditures -332.84 million, giving a free cash flow of 584.82 million.

Operating Cash Flow	917.66M
Capital Expenditures	-332.84M
Free Cash Flow	584.82M
FCF Per Share	0.55

Full Cash Flow Statement

Margins

Gross margin is 58.88%, with operating and profit margins of 4.86% and -2.49%.

Gross Margin	58.88%
Operating Margin	4.86%
Pretax Margin	-1.57%
Profit Margin	-2.49%
EBITDA Margin	7.90%
EBIT Margin	4.86%
FCF Margin	4.97%

Dividends & Yields

This stock pays an annual dividend of 0.13, which amounts to a dividend yield of 0.83%.

Dividend Per Share	0.13
Dividend Yield	0.83%
Dividend Growth (YoY)	-86.88%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.09%
Shareholder Yield	1.92%
Earnings Yield	-1.76%
FCF Yield	3.61%

Dividend Details

Stock Splits

The last stock split was on August 19, 2019. It was a forward split with a ratio of 1.3.

Last Split Date	Aug 19, 2019
Split Type	Forward
Split Ratio	1.3

Scores

Shandong Buchang Pharmaceuticals has an Altman Z-Score of 2.49. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.49
Piotroski F-Score	n/a